Immunotherapy resistance mechanisms and predicting NMIBC patient immune responses.

Primary and Acquired Resistance to Cancer ImmunotherapyПодробнее

Mechanisms of acquired resistance against immunotherapyПодробнее

June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint TherapyПодробнее

Tissue specificity in immune responses when using checkpoint blockade immunotherapy to treat tumorsПодробнее

Predicting responses to immunotherapy in head and neck cancerПодробнее

Immunotherapy Activates the Immune SystemПодробнее

Tumour immunology and immunotherapyПодробнее

Adaptive Immune Resistance to Intravesical BCG in NMIBC: BCG-Unresponsive Clinical TrialsПодробнее

2020 MELANOMA - POSTOW - Understanding Immunotherapy Resistance Mechanisms in MelanomaПодробнее

Overcoming resistance to immunotherapyПодробнее

Predicting Which Bladder Cancer Patients Will Respond to ImmunotherapyПодробнее

Dr. Sharma Discusses Immune Checkpoint Resistance in GU CancersПодробнее

Progress and challenges of immunotherapy for bladder cancerПодробнее

Dr. Galsky on Progression on Immunotherapy in Bladder CancerПодробнее

Characterizing Mechanisms of Response and Resistance to Immune Checkpoint Inhibitor Therapy Using...Подробнее

How melanoma 'deceives' the immune system, increasing resistance to immunotherapyПодробнее

Acquired resistance: facing the challenge of immunotherapy in patients with lung cancerПодробнее

Dr. Galsky on Resistance to Checkpoint Blockade in Metastatic Bladder CancerПодробнее

(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2Подробнее